Quinazolinone derivatives as ALDH-2 inhibitors
    2.
    发明授权
    Quinazolinone derivatives as ALDH-2 inhibitors 有权
    喹唑啉酮衍生物作为ALDH-2抑制剂

    公开(公告)号:US07951813B2

    公开(公告)日:2011-05-31

    申请号:US12062431

    申请日:2008-04-03

    IPC分类号: A61K31/517

    CPC分类号: C07D413/12 C07D239/88

    摘要: Disclosed are novel quinazolinone derivatives of formula: wherein: R1 is optionally substituted phenyl or optionally substituted heteroaryl; R2 is 3-hydroxy, 4-hydroxy, 3-NHR4 or 4-NHR4, in which R4 is hydrogen, —C(O)R5, —C(O)NHR6, or —SO2R6; in which R5 is optionally substituted lower alkyl or optionally substituted lower alkoxy; and R6 is optionally substituted lower alkyl; R3 is hydrogen, lower alkyl, lower alkoxy, or halo; V is oxygen, sulfur, or —NH—; and W is lower alkylene of 1-3 carbon atoms, which are useful as ALDH-2 inhibitors for treating mammals for various disease states, such as treatment for cocaine dependency and alcohol dependency.

    摘要翻译: 公开了下式的新的喹唑啉酮衍生物:其中:R 1是任选取代的苯基或任选取代的杂芳基; R2是3-羟基,4-羟基,3-NHR4或4-NHR4,其中R4是氢,-C(O)R5,-C(O)NHR6或-SO2R6; 其中R 5是任选取代的低级烷基或任选取代的低级烷氧基; 并且R 6是任选取代的低级烷基; R3是氢,低级烷基,低级烷氧基或卤素; V是氧,硫或-NH-; 并且W是1-3个碳原子的低级亚烷基,其可用作用于治疗各种疾病状态的哺乳动物的ALDH-2抑制剂,例如对可卡因依赖性和醇依赖性的治疗。